Global Neuroblastoma Drugs Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15132637 | Publishing Date : 28-Jan-2020 | No. of pages : 93
Detailed TOC of Global Neuroblastoma Drugs Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neuroblastoma Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Neuroblastoma Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Immunotherapy
1.4.4 Others
1.5 Market by Application
1.5.1 Global Neuroblastoma Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Neuroblastoma Drugs Market Perspective (2015-2026)
2.2 Neuroblastoma Drugs Growth Trends by Regions
2.2.1 Neuroblastoma Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Neuroblastoma Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Neuroblastoma Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Neuroblastoma Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Neuroblastoma Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Neuroblastoma Drugs Players by Market Size
3.1.1 Global Top Neuroblastoma Drugs Players by Revenue (2015-2020)
3.1.2 Global Neuroblastoma Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Neuroblastoma Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Neuroblastoma Drugs Market Concentration Ratio
3.2.1 Global Neuroblastoma Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Neuroblastoma Drugs Revenue in 2019
3.3 Neuroblastoma Drugs Key Players Head office and Area Served
3.4 Key Players Neuroblastoma Drugs Product Solution and Service
3.5 Date of Enter into Neuroblastoma Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Neuroblastoma Drugs Historic Market Size by Type (2015-2020)
4.2 Global Neuroblastoma Drugs Forecasted Market Size by Type (2021-2026)
5 Neuroblastoma Drugs Breakdown Data by Application (2015-2026)
5.1 Global Neuroblastoma Drugs Market Size by Application (2015-2020)
5.2 Global Neuroblastoma Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Neuroblastoma Drugs Market Size (2015-2020)
6.2 Neuroblastoma Drugs Key Players in North America (2019-2020)
6.3 North America Neuroblastoma Drugs Market Size by Type (2015-2020)
6.4 North America Neuroblastoma Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Neuroblastoma Drugs Market Size (2015-2020)
7.2 Neuroblastoma Drugs Key Players in Europe (2019-2020)
7.3 Europe Neuroblastoma Drugs Market Size by Type (2015-2020)
7.4 Europe Neuroblastoma Drugs Market Size by Application (2015-2020)
8 China
8.1 China Neuroblastoma Drugs Market Size (2015-2020)
8.2 Neuroblastoma Drugs Key Players in China (2019-2020)
8.3 China Neuroblastoma Drugs Market Size by Type (2015-2020)
8.4 China Neuroblastoma Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Neuroblastoma Drugs Market Size (2015-2020)
9.2 Neuroblastoma Drugs Key Players in Japan (2019-2020)
9.3 Japan Neuroblastoma Drugs Market Size by Type (2015-2020)
9.4 Japan Neuroblastoma Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Neuroblastoma Drugs Market Size (2015-2020)
10.2 Neuroblastoma Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Neuroblastoma Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Neuroblastoma Drugs Market Size by Application (2015-2020)
11 India
11.1 India Neuroblastoma Drugs Market Size (2015-2020)
11.2 Neuroblastoma Drugs Key Players in India (2019-2020)
11.3 India Neuroblastoma Drugs Market Size by Type (2015-2020)
11.4 India Neuroblastoma Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Neuroblastoma Drugs Market Size (2015-2020)
12.2 Neuroblastoma Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Neuroblastoma Drugs Market Size by Type (2015-2020)
12.4 Central & South America Neuroblastoma Drugs Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview and Its Total Revenue
13.1.3 Pfizer Neuroblastoma Drugs Introduction
13.1.4 Pfizer Revenue in Neuroblastoma Drugs Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Teva Pharmaceutical
13.2.1 Teva Pharmaceutical Company Details
13.2.2 Teva Pharmaceutical Business Overview and Its Total Revenue
13.2.3 Teva Pharmaceutical Neuroblastoma Drugs Introduction
13.2.4 Teva Pharmaceutical Revenue in Neuroblastoma Drugs Business (2015-2020)
13.2.5 Teva Pharmaceutical Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview and Its Total Revenue
13.3.3 Johnson & Johnson Neuroblastoma Drugs Introduction
13.3.4 Johnson & Johnson Revenue in Neuroblastoma Drugs Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Details
13.4.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.4.3 Bristol-Myers Squibb Neuroblastoma Drugs Introduction
13.4.4 Bristol-Myers Squibb Revenue in Neuroblastoma Drugs Business (2015-2020)
13.4.5 Bristol-Myers Squibb Recent Development
13.5 United Therapeutics
13.5.1 United Therapeutics Company Details
13.5.2 United Therapeutics Business Overview and Its Total Revenue
13.5.3 United Therapeutics Neuroblastoma Drugs Introduction
13.5.4 United Therapeutics Revenue in Neuroblastoma Drugs Business (2015-2020)
13.5.5 United Therapeutics Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Neuroblastoma Drugs Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Neuroblastoma Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Neuroblastoma Drugs Revenue
Table 3. Ranking of Global Top Neuroblastoma Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Neuroblastoma Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Immunotherapy
Table 7. Key Players of Others
Table 8. Global Neuroblastoma Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Neuroblastoma Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Neuroblastoma Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Neuroblastoma Drugs Market Share by Regions (2015-2020)
Table 12. Global Neuroblastoma Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Neuroblastoma Drugs Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Neuroblastoma Drugs Market Growth Strategy
Table 18. Main Points Interviewed from Key Neuroblastoma Drugs Players
Table 19. Global Neuroblastoma Drugs Revenue by Players (2015-2020) (Million US$)
Table 20. Global Neuroblastoma Drugs Market Share by Players (2015-2020)
Table 21. Global Top Neuroblastoma Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroblastoma Drugs as of 2019)
Table 22. Global Neuroblastoma Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Neuroblastoma Drugs Product Solution and Service
Table 25. Date of Enter into Neuroblastoma Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Neuroblastoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 28. Global Neuroblastoma Drugs Market Size Share by Type (2015-2020)
Table 29. Global Neuroblastoma Drugs Revenue Market Share by Type (2021-2026)
Table 30. Global Neuroblastoma Drugs Market Size Share by Application (2015-2020)
Table 31. Global Neuroblastoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 32. Global Neuroblastoma Drugs Market Size Share by Application (2021-2026)
Table 33. North America Key Players Neuroblastoma Drugs Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Neuroblastoma Drugs Market Share (2019-2020)
Table 35. North America Neuroblastoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 36. North America Neuroblastoma Drugs Market Share by Type (2015-2020)
Table 37. North America Neuroblastoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. North America Neuroblastoma Drugs Market Share by Application (2015-2020)
Table 39. Europe Key Players Neuroblastoma Drugs Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Neuroblastoma Drugs Market Share (2019-2020)
Table 41. Europe Neuroblastoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Neuroblastoma Drugs Market Share by Type (2015-2020)
Table 43. Europe Neuroblastoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Neuroblastoma Drugs Market Share by Application (2015-2020)
Table 45. China Key Players Neuroblastoma Drugs Revenue (2019-2020) (Million US$)
Table 46. China Key Players Neuroblastoma Drugs Market Share (2019-2020)
Table 47. China Neuroblastoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 48. China Neuroblastoma Drugs Market Share by Type (2015-2020)
Table 49. China Neuroblastoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. China Neuroblastoma Drugs Market Share by Application (2015-2020)
Table 51. Japan Key Players Neuroblastoma Drugs Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Neuroblastoma Drugs Market Share (2019-2020)
Table 53. Japan Neuroblastoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Neuroblastoma Drugs Market Share by Type (2015-2020)
Table 55. Japan Neuroblastoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Neuroblastoma Drugs Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Neuroblastoma Drugs Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Neuroblastoma Drugs Market Share (2019-2020)
Table 59. Southeast Asia Neuroblastoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Neuroblastoma Drugs Market Share by Type (2015-2020)
Table 61. Southeast Asia Neuroblastoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Neuroblastoma Drugs Market Share by Application (2015-2020)
Table 63. India Key Players Neuroblastoma Drugs Revenue (2019-2020) (Million US$)
Table 64. India Key Players Neuroblastoma Drugs Market Share (2019-2020)
Table 65. India Neuroblastoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 66. India Neuroblastoma Drugs Market Share by Type (2015-2020)
Table 67. India Neuroblastoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 68. India Neuroblastoma Drugs Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Neuroblastoma Drugs Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Neuroblastoma Drugs Market Share (2019-2020)
Table 71. Central & South America Neuroblastoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Neuroblastoma Drugs Market Share by Type (2015-2020)
Table 73. Central & South America Neuroblastoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Neuroblastoma Drugs Market Share by Application (2015-2020)
Table 75. Pfizer Company Details
Table 76. Pfizer Business Overview
Table 77. Pfizer Product
Table 78. Pfizer Revenue in Neuroblastoma Drugs Business (2015-2020) (Million US$)
Table 79. Pfizer Recent Development
Table 80. Teva Pharmaceutical Company Details
Table 81. Teva Pharmaceutical Business Overview
Table 82. Teva Pharmaceutical Product
Table 83. Teva Pharmaceutical Revenue in Neuroblastoma Drugs Business (2015-2020) (Million US$)
Table 84. Teva Pharmaceutical Recent Development
Table 85. Johnson & Johnson Company Details
Table 86. Johnson & Johnson Business Overview
Table 87. Johnson & Johnson Product
Table 88. Johnson & Johnson Revenue in Neuroblastoma Drugs Business (2015-2020) (Million US$)
Table 89. Johnson & Johnson Recent Development
Table 90. Bristol-Myers Squibb Company Details
Table 91. Bristol-Myers Squibb Business Overview
Table 92. Bristol-Myers Squibb Product
Table 93. Bristol-Myers Squibb Revenue in Neuroblastoma Drugs Business (2015-2020) (Million US$)
Table 94. Bristol-Myers Squibb Recent Development
Table 95. United Therapeutics Company Details
Table 96. United Therapeutics Business Overview
Table 97. United Therapeutics Product
Table 98. United Therapeutics Revenue in Neuroblastoma Drugs Business (2015-2020) (Million US$)
Table 99. United Therapeutics Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuroblastoma Drugs Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Immunotherapy Features
Figure 4. Others Features
Figure 5. Global Neuroblastoma Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Neuroblastoma Drugs Report Years Considered
Figure 10. Global Neuroblastoma Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Neuroblastoma Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Neuroblastoma Drugs Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Neuroblastoma Drugs Market Share by Players in 2019
Figure 15. Global Top Neuroblastoma Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroblastoma Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Neuroblastoma Drugs Revenue in 2019
Figure 17. North America Neuroblastoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Neuroblastoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Neuroblastoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Neuroblastoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Neuroblastoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Neuroblastoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Neuroblastoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Pfizer Revenue Growth Rate in Neuroblastoma Drugs Business (2015-2020)
Figure 26. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Teva Pharmaceutical Revenue Growth Rate in Neuroblastoma Drugs Business (2015-2020)
Figure 28. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Johnson & Johnson Revenue Growth Rate in Neuroblastoma Drugs Business (2015-2020)
Figure 30. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Bristol-Myers Squibb Revenue Growth Rate in Neuroblastoma Drugs Business (2015-2020)
Figure 32. United Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. United Therapeutics Revenue Growth Rate in Neuroblastoma Drugs Business (2015-2020)
Figure 34. Bottom-up and Top-down Approaches for This Report
Figure 35. Data Triangulation
Figure 36. Key Executives Interviewed
Keyplayers in Global Neuroblastoma Drugs Market Size, Status and Forecast 2020-2026
PfizerTeva Pharmaceutical
Johnson & Johnson
Bristol-Myers Squibb
United Therapeutics